Intralesional cidofovir injections for the treatment of multifocal exophytic sinonasal papilloma.

antiviral agents cidofovir exophytic papilloma florid papillomatosis human papillomavirus nasal cavity papillomas nasal tumor

Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
27 Jun 2024
Historique:
revised: 02 06 2024
received: 25 04 2024
accepted: 13 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: aheadofprint

Résumé

Intralesional cidofovir injections in combination with surgery is an effective treatment for recurrent multifocal sinonasal exophytic papilloma. No malignant transformation has been observed in our experience. Anosmia is a potential side effect that patients should be aware of.

Identifiants

pubmed: 38934682
doi: 10.1002/alr.23399
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.

Références

El‐Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ, WHO Classification of Head and Neck Tumours. 4th ed. International Agency for Research on Cancer; 2017.
Glâtre R, De Kermadec H, Alsamad IA, et al. Exophytic sinonasal papillomas and nasal florid papillomatosis: a retrospective study. Head Neck. 2018;40(4):740‐746. doi:10.1002/hed.25042
Terada T. Malignant transformation of exophytic Schneiderian papilloma of the nasal cavity. Pathol Int. 2012;62(3):199‐203. doi:10.1111/j.1440–1827.2012.02795.x
Zagzoog FH, Mogharbel AM, Alqutub A, Bukhari M, Almohizea MI. Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta‐analysis. Eur Arch Otorhinolaryngol. 2024;281:601‐627. doi:10.1007/s00405‐023‐08279‐0
Shemen LJ, Shnayder Y. Office‐based intralesional cidofovir injections for nasal septal papilloma: a pilot study. Otolaryngol Head Neck Surg. 2006;135(1):149‐151. doi:10.1016/j.otohns.2005.12.028
Capaccio P, Ottaviani F, Cuccarini V, et al. Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. Eur Arch Otorhinolaryngol. 2009;266(6):937‐939. doi:10.1007/s00405‐008–0769‐7

Auteurs

Florian Chatelet (F)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
Faculté de Santé, UFR de Médecine, Université Paris Cité, Paris, France.

Alessandro Vinciguerra (A)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.

Morgane Marc (M)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
Faculté de Santé, UFR de Médecine, Université Paris Cité, Paris, France.

Philippe Herman (P)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
Faculté de Santé, UFR de Médecine, Université Paris Cité, Paris, France.

Benjamin Verillaud (B)

Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
Faculté de Santé, UFR de Médecine, Université Paris Cité, Paris, France.

Classifications MeSH